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Mapping the evidence on interventions to
raise awareness on lung cancer in resource
poor settings: a scoping review protocol
Siyabonga B. Dlamini1* , Benn Sartorius1,2,3 and Themba Ginindza1
Abstract
Background: Lung cancer is the most commonly diagnosed cancer with 11.6% of the total cases attributable
to lung cancer. It is currently the leading cause of death among cancer-related deaths worldwide. This is a
major public health concern. Death due to lung cancer is preventable with interventions encouraging early
presentation, diagnosis, smoking cessation and prompt and proper treatment. Literature shows that people
are willing to screen for lung cancer if they understand the related risk, because of their behaviour, thus,
highlighting the need for tailored interventions to address the associated risks. The aim of the review is to
map the available literature on interventions raising community awareness about lung cancer (knowledge,
attitudes and health-seeking behaviour) and effectiveness thereof among adults in resource-poor settings.
Methods and analysis: A methodological framework of Arksey and O’Malley will be used to guide this scoping
review of published data. This process will start by searching several databases, including the Cochrane Library,
PubMed, Scopus, MEDLINE, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycInfo, Web of
Science, Google Scholar and the Educational Resources Information Centre (ERIC). A two-stage process will be done,
where, firstly, two reviewers will independently screen the titles and abstracts for eligibility to be included in the final
selection of studies. Secondly, a full-text screening of the articles from selected titles and abstracts will then be
conducted. A tool developed through an iterative process by the researchers will be used to analyse all
bibliographic data and study characteristics of selected studies.
Discussion: The results will be used to inform policy and practice in terms of developing interventions on
lung cancer awareness. The results of this scoping review will be disseminated through scientific publication,
conferences and future workshops with health care professionals involved in lung cancer awareness campaigns.
Keywords: Lung cancer, Community awareness, Interventions, Resource limited settings and effective
Background
Cancer morbidity and mortality is increasingly becoming
a major public health problem, and it is the second lead-
ing cause of death worldwide [1]. Globally, over 20
million new cancer cases are projected for 2025 com-
pared to about 14.1 million and 17.5 million new cases
in 2012 and 2015, respectively [1–4]. Global cancer cases
increased by 33% between 2005 and 2015 [1]. Lung can-
cer accounted for about 1.8 million of all cancer cases
diagnosed in 2012 [4]. Lung cancer is the most
commonly diagnosed cancer with 11.6% of the total
cases attributable to lung cancer [5]. There were over
1.5 million deaths in 2012 due to lung cancer [4]. Lung
cancer is currently the leading cause of death among can-
cer-related deaths worldwide [5, 6] and is thus a major
public health concern. Low- and middle-income countries
(LMICs) face an increasing challenge of cigarette use and
availability of tobacco products [7–9]. Death due to lung
cancer is preventable with interventions encouraging early
presentation and diagnosis, smoking cessation and prompt
and proper treatment [6, 9–11]. Islami and colleagues ar-
gued that prevention interventions were needed to curb
lung cancer morbidity and mortality in most African
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countries and other LMICs as a result of increased use of
tobacco products [9].
A study conducted in Malaysia among smokers and
non-smokers showed that people were willing to go for
screening, if they were informed that they were particu-
larly at high risk of lung cancer, especially if they were
smokers [11]. Whilst prevention is undeniably the best
way to address lung and other cancers, challenges
brought about by modern lifestyles are not making this
approach any easier. For example, modern lifestyles,
socio-economic developments and technologically com-
plex human and built environments have profound
effects on the scale and profile of cancer; hence, LMICs
are now experiencing the greatest increase in cancer in-
cidence [3].
Williams et al. [12] propose multiple interventions in-
cluding cancer awareness, advocacy, research, workforce
care training and funding to avert this situation. Further-
more, there is poor access to quality of care for cancer
in SSA, and South Africa is less than optimal [13]. An
overwhelming majority of lung cancer patients are diag-
nosed late and are thus initiated on treatment late. This
reduces the effectiveness of treatment, which results in
the majority of lung cancer patients dying whilst on
treatment [14–17]. This suggests that there are barriers
to early diagnosis of lung cancer. These barriers may in-
clude (i) structural factors, where patient pathways of
care may hinder early diagnosis, (ii) lack of proper
health-seeking behaviour, where the patients do not go
to health facilities early so that they are screened and
initiated on life-saving treatment early, and (iii) cultural
beliefs that serve as barriers for individuals to seek help
early [16, 18–20]. Hence, there is a need for better
awareness and early detection.
This article outlines the protocol for a scoping review
of published literature focusing on interventions that
have been proposed and/or implemented to raise com-
munity awareness about lung cancer (knowledge,
attitudes and health-seeking behaviour) among adults in
resource-poor settings.
Methods
Protocol design
The scoping review is informed by the framework pro-
posed by Arksey and O’Malley [21] which has been
further developed by Levac et al. [22] and the Joanna
Briggs Institute [23]. This framework recommends to or-
ganise the review process in at least five stages [21].
These stages are (1) identifying the research question,
(2) identifying relevant studies, (3) study selection, (4)
charting the data, and (5) collating, summarising and
reporting the results.
These stages and how they will be applied in the pro-
posed scoping review are discussed below.
Framework stage 1: Identifying the research question
The design of this protocol has been informed by the
scanning of the existing literature. This exercise assisted
in the development of the research question to guide the
scope of the review. The broad research question this
scoping review will attempt to answer: “What is the
effect of community awareness interventions on lung
cancer in resource-poor settings?” The review will give
an overview of the various interventions available,
appraise their effectiveness and identify barriers and fa-
cilitators to their effectiveness.
Framework stage 2: Identifying relevant studies
Identification of studies relevant to this review will be
achieved by searching electronic databases of the
published literature (including published systematic re-
views). These electronic databases include Cochrane Li-
brary, PubMed, Scopus, MEDLINE, the Cumulative Index
to Nursing and Allied Health Literature (CINAHL),
PsycInfo, Web of Science, Google Scholar, EMBASE and
the Educational Resources Information Centre (ERIC). All
reference lists of included studies will be searched to iden-
tify additional relevant studies. A variety of grey literature
sources will also be searched to ensure that all relevant in-
formation is captured. Relevant grey literature databases
(such as Grey Literature Report, OpenGrey, Web of
Science Conference Proceedings) will be searched to iden-
tify studies, reports and conference abstracts applicable to
this review (Additional file 2).
The inclusion criteria will include (i) language of pub-
lication: English, (ii) timeframe: no time frame, (iii) study
setting: resource-poor setting, and (iv) types of articles:
randomised controlled trials, intervention studies (in-
cluding quasi-experimental designs), reports, literature
reviews and evidence maps. Studies will be excluded if
they do not meet any of the listed criteria.
Search terms will be determined with input from the
research team and in consultation with and academic
librarian. However, the following are some of the key-
words that are likely to be used to search for articles:
lung cancer, awareness, community, interventions, and
effective. Terms will be searched as both keywords in
the title, abstract and/or subject headings (i.e. MeSH
terms). The review articles retrieved were then screened
for their titles, abstracts and index terms. The articles
retrieved from each database will be imported into a ref-
erence management software, namely EndNote. Endnote
will be used for managing records, keeping track of arti-
cles and producing a list of references included in the
final review report.
Framework stage 3: Study selection
The review of articles will have two levels of screening.
The first level will be title and abstract review, where
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two team members will independently screen the title
and abstract of all retrieved citations for inclusion
against a set of minimum inclusion criteria; the second,
full-text review. Initially, a sample of the retrieved
articles will be independently screened by two team
members to ensure consistent application of the eligibil-
ity criteria for inclusion in the review. Any articles
deemed relevant by one or both of the reviewers will be
included in the full-text review. Inter-rater reliability will
be assessed using percentage agreement. Once the per-
centage agreement reaches 80% or above, advancement
to the next stage can be done. For lower agreement, the
inclusion and exclusion criteria will be clarified. The
team will ensure that the duplicates from the different
search databases are eliminated. A member of the team
will then screen titles and abstracts of the articles to
exclude those that do not meet the eligibility criteria
identified in the second stage of the protocol. The full-
text articles will be retrieved for the titles and/or
abstracts meeting the inclusion criteria.
Disagreements about study eligibility of the sampled ar-
ticles will be discussed between the two reviewers until a
consensus is reached or by arbitration of a third reviewer,
if required. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) flow chart [24–26]
will be used to report on the selection process of studies
included in this review (see Additional file 1).
Framework stage 4: Charting the data
Key pieces of information from the abstracts of the se-
lected articles will be collected and sorted. Standard data
items will be extracted from the published research lit-
erature that will include author, year of publication,
study objectives and additional information (i.e. type of
study and objectives of the study, intervention strategies
on lung cancer awareness and target populations) and
will be reported. Based on the preliminary scoping
phase, a data extraction framework was developed which
will guide the full review articles retrieved from the lit-
erature fulfilling the eligibility criteria for inclusion
(Table 1). For each article, information on the interven-
tions covered by the review, characteristics of the study
populations, setting, length and intensity of the interven-
tions, types of outcomes assessed, information on the
effectiveness of the interventions and facilitators and
barriers for the implementation of the interventions will
be tabled.
The framework will be pilot tested by two team
members on a sample (30%) of the included studies
in order to ensure that the coding framework is con-
sistently applied. Additional categories may emerge
during the pilot testing process. If necessary, the
categories will be modified and the data extraction
framework revised accordingly. Questions arising
when piloting the framework will be discussed by the
team and possible disagreement will be resolved
through team consultations. Missing data may be
found on some eligible abstracts, and this will be re-
solved and documented in consultation with the team
members. The authors of those articles will be con-
tacted in an attempt to obtain the required details. If
there is no response from the authors in 2 to 3
weeks, this will be considered as no information avail-
able. However, the study will be included in the nar-
rative with a mention that an attempt was made to
contact the authors for the missing data.
Table 1 Data extraction framework
Main category Sub-category Description
1. Authors
2. Title
3. Journal
4. Year of publication
5. Objectives of the article Description of the study objectives
6. Type of study Primary (knowledge)
Multiple outcomes (health-seeking
behaviour, knowledge)
RCT, quasi-experimental, etc.
7. Country(ies) where the study
was conducted
Where was this study conducted (Geographical distribution)
8. Language Language used in the intervention/publication
9. Target population Individual
Community, etc.
Individual or group (community)
Specific age group
Specific sex/gender
10. Setting of the intervention Community-based, facility-based, urban, rural, resource-poor, etc.
11. Effectiveness Intended intervention outcomes, results presented by authors, future
research directions identified by authors
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The team members that were piloting the framework
will be responsible for independently charting the data
from each included review study. Similarly, disagree-
ments in extracted data between the two members will
be discussed by these members until a consensus is
reached or by arbitration of a third reviewer, if required.
Framework stage 5: Collating, summarising and reporting
the results
This review seeks to compile a summary of findings and
then propose a “best” model/intervention in a resource-
poor setting broadly present an overview of a particular
area of interest. The study will present a narrative account
of existing literature using thematic construction based on
the different identified intervention types from the selected
studies. The analysis of the data collected using the data
extraction framework, in this scoping review, will provide
information on the body of research that has been con-
ducted on interventions to raise awareness on lung cancer
in resource-poor settings. It will be able to provide informa-
tion on the types of evidence available, the aggregated find-
ings, and offer an outline of the published research rather
than an assessment of the quality of individual studies. It
would also highlight the effectiveness of the interventions
reviewed and their material impact on the target popula-
tions. It is also beneficial in identifying gaps in the existing
body of knowledge and future research topics.
Discussion
The results from this scoping review will inform the
development of a tailored community lung cancer
awareness intervention targeted at selected communities
in KwaZulu-Natal, South Africa. This study does not
require ethical approval, since the scoping review meth-
odology comprises of reviewing and collecting data from
publicly available publications and materials. The results
of this scoping review will be disseminated through sub-
mitting an article for publication to a scientific journal,
conferences, presentations and reports to policymakers
and future workshops with professionals involved in
lung cancer awareness campaigns. The results will pro-
vide a complete synopsis of the interventions on lung
cancer awareness and highlight areas where evidence is
controversial or missing.
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